Fatal Mucor pneumonia after treatment with 2-chlorodeoxyadenosine for non-Hodgkin's-lymphoma

Ann Hematol. 1996 Sep;73(3):145-7. doi: 10.1007/s002770050217.

Abstract

Fungal infections, in addition to bacterial and opportunistic infections such as Pneumocystis carinii pneumonia, may evolve in patients with infectious complications due to iatrogenic immunosuppression. Aside from common Candida and Aspergillus species, rare fungi like Mucor must be considered in patients with neutropenia or prolonged impaired T-cell function. Here we report on a patient with a low grade lymphoma who was treated with 2-chlorodeoxyadenosine because of disease progression. After recovery from Pneumocystis carinii pneumonia he presented again with clinical signs of pneumonia. No pathogen was found on bronchoscopy and he died rapidly. In the lungs a massive necrosis was seen in which nonseptated hyphae identified as Mucor species were demonstrated.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Cladribine / adverse effects*
  • Cladribine / therapeutic use
  • Fatal Outcome
  • Humans
  • Immunosuppressive Agents / administration & dosage
  • Immunosuppressive Agents / therapeutic use
  • Lymphoma, Non-Hodgkin / drug therapy*
  • Male
  • Mucormycosis / etiology*
  • Pneumonia / microbiology*
  • Pneumonia / pathology

Substances

  • Immunosuppressive Agents
  • Cladribine